Sangamo Biosciences reported $406.02M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Amgen AMGN:US $ 8217M 30M
Avrobio Inc AVRO:US $ 193.57M 27.42M
Bayer BAYN:GR € 31103M 714M
Biocryst Pharmaceuticals BCRX:US $ -147.04M 40.97M
Biogen BIIB:US $ 10429.9M 322M
Biomarin Pharmaceutical BMRN:US $ 4266.15M 24.58M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Gilead Sciences GILD:US $ 21471M 1768M
GlaxoSmithKline GSK:LN 15426M 49M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
IONIS PHARMACEUT IONS:US $ 531M 51.67M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Novartis NOVN:VX SF 56771M 2729M
Omeros OMER:US $ -262697000 16.4M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Sarepta Therapeutics SRPT:US $ 469.53M 15.58M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
Vertex Pharmaceuticals VRTX:US $ 9530.71M 334.31M
Ziopharm Oncology ZIOP:US $ 68.71M 19.57M